Mission Bio Secures Equity Financing to Accelerate Single-Cell Tri-omics Platform Expansion

Investment to Drive Commercial Growth, Advance Single-Cell Tri-omics Capabilities and Clinical Applications Across Cancer Company Adds to Leadership Team, with Matthew H. Cato Joining as CCO SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced the successful completion of equity financing led by Ally Bridge Group. [...]

Promega, Aobious Resolve Patent Infringement Lawsuit

Consent Judgment confirms Aobious infringed Promega patents covering luciferase substrate compounds Settlement includes permanent injunction against Aobious and monetary payments to Promega Promega reaffirms commitment to providing high-quality reagents to scientists through authorized distribution channels MADISON, Wis.--Promega Corporation and Aobious Inc. have entered into a settlement agreement to resolve a patent infringement lawsuit related to [...]

ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine

ST. PAUL, Minn. -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sidra Medicine, a women and children's hospital in Qatar, has been awarded a $100,000 G-Rex® Grant. Sidra Medicine's G-Rex® Grant will enable expeditious development, validation, and implementation of a G-Rex® centric CAR-T cell production platform. The G-Rex Grant [...]

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

BOSTON and ROLLE, Switzerland -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca (LSE/STO/Nasdaq: AZN). This new, multi-year collaboration will leverage SOPHiA GENETICS's multimodal AI Factories to generate evidence on the efficacy, value, and real-world impact of therapies for certain types [...]

Smiths Detection Announces Acquisition of Med Graphix Inc.

EDGEWOOD, Md. -- Smiths Detection today announces its acquisition of New Jersey-based Med Graphix Inc. ("MGI"), enhancing the company’s sustainable service offering by extending the lifecycle of critical components through repair, refurbishment, and reuse. MGI has been a long-standing service partner and third-party depot supplier for Smiths Detection. This deal marks a significant milestone in [...]

Introducting POLLUX: Our Most Versatile XRD detector yet

We’re proud to unveil POLLUX™, the latest addition to our family of laboratory X-ray detectors - and our most versatile one yet. Built on decades of expertise in Hybrid Photon Counting (HPC) technology, POLLUX was specifically developed for laboratory XRD, empowering scientists and instrument developers with fast, accurate, and energy-discriminating X-ray detection. POLLUX™ redefines what [...]

908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors

BOSTON -- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Dr. Brandi Vann to serve on its Board of Directors. During more than 15 years at the U.S. Department of Defense (DoD), Dr. Vann held several leadership positions overseeing nuclear, chemical, and biological defense [...]

Pablo Perversi to Join METTLER TOLEDO Board of Directors

COLUMBUS, Ohio -- Mettler-Toledo International Inc. (NYSE: MTD) announced today that Pablo Perversi has been appointed to its Board of Directors, effective November 6, 2025. Mr. Perversi is the President of Europe at Danone, a leading global food and beverage company, and a member of its Executive Committee. Prior to his current role, Pablo served [...]

MaxCyte Signs Platform License Agreement with Adicet Bio

MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support development of Adicet’s gamma delta T cell therapy gene edited programs ROCKVILLE, Md -- MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics, today announced it has signed a strategic platform license [...]

Gatan launches the EDAX Orbis II Micro-XRF system

PLEASANTON, CA – Gatan, Inc., a business of AMETEK, Inc. as well as a global leader focused on enhancing and extending the operation and productivity of electron microscopes, has launched the EDAX® Orbis™ II System, designed to support a wide range of non-destructive elemental analysis that use micro x-ray fluorescence (micro-XRF). The Orbis II System directly addresses two [...]

Access IBO on Knowledge Center